T1	outcome 1051 1062	5-years DFS
T2	outcome 956 965	5-year OS
T3	total-participants 415 420	2,887
T5	eligibility 71 180	node-positive breast cancer patients treated with docetaxel  and doxorubicin-containing adjuvant chemotherapy
T7	intervention-participants 860 863	547
T8	control-participants 909 914	2,340
T9	cv-bin-percent 970 975	87.5%
T10	iv-bin-percent 994 999	82.9%
T11	cv-bin-percent 1067 1072	75.9%
T12	iv-bin-percent 1090 1095	70.0%
T14	intervention 884 889	obese
T15	control 935 944	non-obese
